Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RxSight (RXST) Total Liabilities (2020 - 2025)

RxSight (RXST) has disclosed Total Liabilities for 6 consecutive years, with $36.1 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Total Liabilities fell 3.2% year-over-year to $36.1 million, compared with a TTM value of $36.1 million through Dec 2025, down 3.2%, and an annual FY2025 reading of $36.1 million, down 3.2% over the prior year.
  • Total Liabilities was $36.1 million for Q4 2025 at RxSight, up from $32.6 million in the prior quarter.
  • Across five years, Total Liabilities topped out at $301.9 million in Q1 2021 and bottomed at $19.2 million in Q1 2024.
  • Average Total Liabilities over 5 years is $54.3 million, with a median of $37.7 million recorded in 2023.
  • The sharpest move saw Total Liabilities plummeted 88.16% in 2021, then soared 75.34% in 2025.
  • Year by year, Total Liabilities stood at $54.5 million in 2021, then rose by 10.62% to $60.3 million in 2022, then crashed by 63.18% to $22.2 million in 2023, then soared by 68.22% to $37.3 million in 2024, then decreased by 3.2% to $36.1 million in 2025.
  • Business Quant data shows Total Liabilities for RXST at $36.1 million in Q4 2025, $32.6 million in Q3 2025, and $31.0 million in Q2 2025.